Skip to main content
Clinical Trials/NCT02406313
NCT02406313
Unknown
Not Applicable

Evaluation of the Efficiency of a Therapeutic Education Program in Standardized Thermal Cure for Fibromyalgia Patients

Association Francaise pour la Recherche Thermale1 site in 1 country152 target enrollmentMarch 2015
ConditionsFibromyalgia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fibromyalgia
Sponsor
Association Francaise pour la Recherche Thermale
Enrollment
152
Locations
1
Primary Endpoint
Change in quality of life
Last Updated
7 years ago

Overview

Brief Summary

The study evaluates the efficiency, in terms of quality of life improvement, of a patient's therapeutic education program (ETP), based on long term commitment in adapted physical activities carried out during a standardized thermal cure (CTS) for fibromyalgia among patients continuing regular drug treatment or not

Detailed Description

Fibromyalgia is a poorly known and understood disease. Patients suffer from pain, fatigue, sleep disorders, anxiety, depression, preventing them from moving and going out, resulting in an alteration of social life. Multiple drugs treatment is frequently used but is burdensome and poorly effective. However, thermal cure proved efficacious to improve quality of life during the cure and beyond. This study aims at demonstrating the added value of a patient's therapeutic education program provided during a thermal cure, a moment where patients are available and receptive to guidance.

Registry
clinicaltrials.gov
Start Date
March 2015
End Date
December 31, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Association Francaise pour la Recherche Thermale
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in quality of life

Time Frame: Month 06 after cure completion

Change from baseline in quality of life assessed through the self-administered Fibromyalgia Impact Questionnaire (FIQ) month 06 after cure completion.

Secondary Outcomes

  • Pain intensity(Week 03, Month 03, Month 06, Month 12)
  • Function impairment(Week 03, Month 03, Month 06, Month 12)
  • Responder rate(Week 03, Month 03, Month 06, Month 12)
  • Somnolence(Week 03, Month 03, Month 06, Month 12)
  • Serious adverse reactions (SARs)(Day 00 to Month 12)
  • non-drug treatment consumption(Day 00, Week 03, Month 03, Month 06, Month 12)
  • Kinesiophobia index(Week 03, Month 03, Month 06, Month 12)
  • Anxiety and depression(Week 03, Month 03, Month 06, Month 12)
  • drug consumption(Day 00, Week 03, Month 03, Month 06, Month 12)
  • Thermal outbreaks(Day 00 to Week 03)
  • Change in quality of life(Week 03, Month 03, Month 12)
  • Pain relief(Week 03, Month 03, Month 06, Month 12)
  • Catastrophizing index(Week 03, Month 03, Month 06, Month 12)
  • Fatigue(Week 03, Month 03, Month 06, Month 12)
  • Fibromyalgia outbreaks(Week 03 to Month 12)

Study Sites (1)

Loading locations...

Similar Trials